Home Quality assurance and quality control in the routine molecular diagnostic laboratory for infectious diseases
Article Publicly Available

Quality assurance and quality control in the routine molecular diagnostic laboratory for infectious diseases

  • Harald H. Kessler

    Dr. Harald H. Kessler obtained his MD from the University of Graz, Medical School in 1985. In 1994, he became a Specialist in Laboratory Medicine and the Laboratory Director for the Molecular Diagnostics Laboratory and Reference Laboratory for Hepatitis A, B, C. In 1997, he became an Associated Professor of Laboratory Medicine. In 1998, he became a legal expert on Laboratory Medicine. In 1999, Dr. Kessler became a European Clinical Chemist (EU-EC4). In 2003, he met the requirements of the European Board of Medical Biopathology for foundation fellowship in the speciality of Polyvalent Medical Biopathology. In 2005, he became the Director of the Research Unit of Molecular Diagnostics of Pathogens. In 2008, he became a University Professor. Since 2009, he has been a board member of the Austrian Society of Laboratory Medicine and Clinical Chemistry. He is the author of 176 publications including 96 SCI and PubMed articles (excluding abstracts from meetings), 10 book chapters, and one scientific book.

    EMAIL logo
    and Reinhard B. Raggam

    Dr. Reinhard B. Raggam obtained an MD from the University of Graz, Medical Faculty in 2002 and completed his specialty in Laboratory Medicine (Medical Biopathology) at the Institute of Hygiene, Microbiology and Environmental Medicine, and at the Department of Internal Medicine, Section of Infectious Diseases in 2010. His research mainly concerns diagnostics in infectious diseases and he has published more than 30 original articles and several book chapters in this field. He teaches at the Medical University of Graz and currently holds a position as Adjunct Professor for Laboratory Medicine. He serves as a member of the advisory board of the Young Laboratory Physicians of the Austrian Society of Laboratory Medicine and Clinical Chemistry and is a corresponding member of the IFCC Task Force Young Scientists.

Published/Copyright: February 3, 2012

Received: 2011-09-29
Accepted: 2011-12-25
Published Online: 2012-02-03
Published in Print: 2012-07-01

©2012 by Walter de Gruyter Berlin Boston

Articles in the same Issue

  1. Masthead
  2. Masthead
  3. Editorial
  4. Fit for Future – Help Healing the World: IFCC-WorldLab in Berlin 2011
  5. Reviews
  6. European medical laboratory accreditation. Present situation and steps to harmonisation
  7. Quality assurance and quality control in the routine molecular diagnostic laboratory for infectious diseases
  8. Translating exome sequencing from research to clinical diagnostics
  9. Laboratory approaches for predicting and managing the risk of cardiovascular disease: postanalytical opportunities of lipid and lipoprotein testing
  10. Pregnancy-associated plasma protein A: spotlight on kidney diseases
  11. Measurement of factor XIII activity in plasma
  12. Update on multiple sclerosis, its diagnosis and treatments
  13. Recommendations on prenatal screening and the connections to other diseases such as thyroid dysfunction
  14. Mini Reviews
  15. Experience of Médecins Sans Frontières in laboratory medicine in resource-limited settings
  16. Highlights in inflammatory bowel disease – from bench to bedside
  17. Opinion Papers
  18. Implementation of standardization in clinical practice: not always an easy task
  19. IFCC standardised HbA1c: should the world be as one?
  20. Reflective testing: adding value to laboratory testing
  21. Original Articles
  22. Low angle light scattering analysis: a novel quantitative method for functional characterization of human and murine platelet receptors
  23. The recoveryELISA – a newly developed immunoassay for measurement of therapeutic antibodies and the target antigen during antibody therapy
  24. Implementation of new recommendations for the diagnosis of gestational diabetes: a 5-month audit
  25. Exploring synergies between academia and vaccine manufacturers: a pilot study on how to rapidly produce vaccines to combat emerging pathogens
Downloaded on 5.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2011-0707/html?lang=en&srsltid=AfmBOoq0A8vEu2IFqWtxEgOGZpw4iIPaMNyYQlq2Qp8EOgi9F6KVjkVz
Scroll to top button